To investigate the effect of genipin on apoptosis in human leukemia K562 cells in vitro and elucidate the underlying mechanisms. Methods: The effect of genipin on K562 cell viability was measured using trypan blue dye exclusion and cell counting. Morphological changes were detected using phase-contrast microscopy. Apoptosis was analyzed using DNA ladder, propidium iodide (PI)-labeled fl ow cytometry (FCM) and Hoechst 33258 staining. The infl uence of genipin on cell cycle distribution was determined using PI staining. Caspase 3 activity was analyzed to detect apoptosis at different time points. Protein levels of phospho-c-Jun, phosphor-c-Jun N-terminal kinase (p-JNK), phosphor-p38, Fas-L, p63, and Bax and the release of cytochrome c were detected using Western blot analysis. 
Introduction
Genipin (Figure 1 ), an iridoid compound, is an aglycone derived from geniposide. It is the major active ingredient of Gardenia jasminoides Ellis fruit, which has long been used in traditional Chinese medicine [1, 2] . Genipin has a molecular weight of 226 and a white crystalline structure. It is soluble in ethanol and ethyl acetate and slightly soluble in water. It also has a low cytotoxicity [2] . Pharmacokinetic studies suggested that geniposide is hydrolyzed into genipin by β-Dglucosidases in the intestine and liver [3] . It is genipin, not geniposide, which functions as the main bioactive compound and exhibits the pharmacological activities of the gardenia [4] . Genipin is used to prepare blue colorants in the food industry and as a crosslinking reagent for biological tissue fixation [5] . Additionally, genipin has also been shown to possess various pharmacological actions such as anti-inflammatory [2, 6] , antiangiogenic [7] , antithrombotic [8] , anti-diabetic [9] , and antioxidative [10] properties, the inhibition of NO production [2] and the protection of neurotrophic activities [11] . Genipin inhibits endothelial exocytosis in human umbilical vein endothelial , suppresses vascular and endothelial cell infl ammatory activation, and may target acute infl ammatory events [12] . Notably, genipin has been shown to induce dosedependent apoptosis in FaO rat hepatoma cells, human hepatocarcinoma Hep3B cells [13] and PC3 human prostate cancer cells [14] . However, whether genipin shows a potential effect on human leukemia K562 cells and the cellular signaling pathway involved in this potential effect have not been well elucidated.
Stress-activated protein kinase/c-Jun NH 2 -terminal kinase (SAPK/JNK 1/2 ), a member of the mitogen-activated protein kinase (MAPK) family, is highly activated in response to a variety of stress signals including chemotherapy drugs, tumor necrosis factor, hyperosmotic stress and ultraviolet irradiation. Its activation is most frequently associated with the induction of apoptosis [15] [16] [17] . Activated JNK specifically catalyzes the phosphorylation of c-Jun on its N-terminal transactivation domain at Ser63 and Ser73. Phosphorylation of c-Jun, a major target of JNK, is a signal of JNK activation [18] . The death domain-containing receptor Fas and its ligand Fas-L have mainly been studied with respect to their ability to induce apoptosis. JNK/Fas mediation of the apoptotic pathway has been reported in previous studies of genipin [19] . In the present study, we investigated the effect of genipin on apoptosis in human leukemia K562 cells and elucidated the molecular mechanism of cell apoptosis. The results showed that genipin induced apoptosis in K562 cells via blockage of cell cycle progression at the G 2 /M phase and the subsequent progression into apoptosis through a multi-signaling pathway.
Materials and methods

Materials
The human leukemia cell line K562 was kindly provided by Professor Sheng-fu LI (Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China). Genipin (98%, Figure 1 ) was purchased from Haikang Biotechnology Co, Ltd (Chengdu, China) and dissolved in distilled water (13.1 mg/mL, pH 7.4). The solution of genipin was filtered with Millipore filtration and stored at -20 °C. Triton X-100, Tris base, SDS, acrylamide, bisacrylamide, ammonium persulfate and TEMED were from Amresco Co (Solon, OH, USA). RPMI-1640 medium was from Gibco Co (Langley, USA). Fetal bovine serum (FBS) was from HyClone Co (Beijing, China). Antibodies against p63, β-actin, Bax and cytochrome c were from Cell Signaling Technology Co (Boston, USA). Phosphorylated antibodies (anti-phosphor-JNK, anti-phosphor-c-Jun, and anti-phosphor-p38) were purchased from Cell Signaling Technology Co (Boston, USA). The antibody against Fas-L was from Millipore Co (Billerica, USA). The 0.25% Trypsin/EDTA solution, penicillin and streptomycin were from Beijing Solarbio Science & Technology Co, Ltd (Beijing, China). Peroxidase-conjugated Affi niPure goat antirabbit and goat anti-mouse immunoglobulin were from ZSGB-BIO Co, Ltd (China). Dicoumarol (a JNK inhibitor) was purchased from NICPBP (Beijing, China). PVDF paper and the enhanced chemiluminescence (ECL) Western blot detection system were purchased from Millipore Co (Billerica, USA).
Trypan blue was from Sigma Co (USA). The Apoptosis DNA Ladder Detection Kit and the Caspase 3 Activity Assay Kit were from the Beyotime Institute of Biotechnology Co (Nanjing, China). The Apoptotic Body/Nuclear DNA Staining Kit was from Bio Basic Inc (Toronto, Canada). All stock solutions were stored at 4 or -20 °C. All other chemicals were of analytical grade.
Cell culture K562 cells were cultured in RPMI-1640 medium with 10% (v/v) heat-inactivated FBS, 100 U/mL penicillin and 100 μg/mL streptomycin in humidifi ed atmosphere at 37 °C with 5% CO 2 . Cells were seeded at a density of 5×10 4 in 100-mm Petri dishes and incubated for 6 h before drug treatment. Various concentrations of genipin were added to each well. Experiments were performed in triplicate.
Cell viability assays
Cell viability was determined by direct cell counting. K562 cells were cultured in 24-well plates at a density of 2×10 4 cells/well for 6 h and then incubated with various concentrations of genipin (100, 200, 300, 400, and 500 μmol/L) for 24 h. The cells were then stained with trypan blue dye and counted with a hemocytometer. The result was expressed as a percentage relative to the control, and the IC 50 values were calculated.
Morphological observation of cells
After being cultured at 37 °C for 6 h in 100-mm Petri dishes, K562 cells were treated with various concentrations of genipin (0, 200, 300, and 400 μmol/L) for 24 h. K562 cells were observed with a phase-contrast microscope (Leica DMIRB, Germany).
Analysis of DNA fragmentation
After incubation with the designated concentrations of genipin (200, 300, 400, and 500 μmol/L) for 24 h, 1×10 6 K562 cells were collected. Genomic DNA was extracted from untreated and genipin-treated cells using the Apoptosis Ladder Detection Kit. The DNA was then electrophoresed in a 1.0% agarose gel and visualized by ethidium bromide (EB) staining. The gel was photographed under ultraviolet light.
Caspase 3 activity assay Caspase 3 activity in cytosolic extracts was determined using a spectrophotometric assay as described by Song et al [20] . Briefl y, supernatants from cell lysates treated with 400 μmol/L genipin for different amounts of time were incubated at 37 °C with Ac-DEVE-MCA, a fl uorogenic substrate of caspase 3. Cleavage of the substrate was monitored at 405 nm. Data were normalized for the protein content of each supernatant and expressed as the relative value compared to the untreated group (time 0 h).
Flow cytometric analysis of the cell cycle and apoptosis
To further measure the apoptosis induction activity of genipin, K562 cells were incubated for 24 h in 6-well plates with geni-www.chinaphar.com Feng Q et al Acta Pharmacologica Sinica npg pin. Cells were then harvested, washed twice with ice-cold phosphate-buffered saline (PBS) and fi xed with 70% ethanol at 4 °C. Before the samples were analyzed the DNA was stained on ice with 200 μL of cold (4 °C) propidium iodine (PI) for 10 min in the dark. DNA-bound PI fl uorescence was measured using a 15 mW air-cooled argon ion laser at 488 nm as the excitation source and an EPICS ELITE ESP fl ow cytometer (Beckman Coulter, USA). Analysis of the cell cycle was performed with Coulter Elite 4.5 Multicycle software. Ten thousand events were recorded for each sample [21] .
Electrophoresis and immunoblotting K562 cells were treated for 24 h with different concentrations of genipin (200, 300, 400, and 500 μmol/L). The cells were then harvested and washed with PBS. Whole cell lysates were obtained using cell lysis solution [250 mmol/L NaCl, 50 mmol/L Tris-HCl (pH 7.4), 0.1% SDS, 1% Triton X-100, 1 mmol/L EDTA, 50 mmol/L NaF, and 1 mmol/L PMSF], followed by centrifugation (12 000×g, 30 min). Protein samples were heated at 95 °C for 5 min, normalized to a total of 100 μg per lane, resolved by SDS-PAGE, transferred onto PVDF membranes (Millipore) by electroblotting, and probed with antibodies against phosphor-JNK, phosphor-c-Jun, phosphor-p38, p63, Bax, Fas-L, and cytochrome c. Primary antibodies were detected with goat anti-rabbit antibody conjugated to horseradish peroxidase using enhanced chemiluminescence with the Immobilon TM Western Chemiluminescent HRP Western blotting detection system (Millipore). Photographs were taken with the ChemiDoc XRS automatic photomicrograph system (Bio-RAD, USA) and analyzed using Quantity One software.
Analysis of cytochrome c release K562 cells were collected by centrifugation at 300×g for 5 min at 4 °C and lysed with cell lysis solution for the mitochondrial cytochrome c release assay. Samples were then centrifuged at 12 000×g at 4 °C for 30 min. Supernatants containing the cytosolic proteins were recovered and analyzed using Western blotting.
Hoechst 33258 staining Nuclear fragmentation of K562 cells treated with 400 μmol/L genipin was visualized by Hoechst 33258 staining following the use of the Apoptotic body/Nuclear DNA Staining Kit (Canada). Briefly, K562 cells were cultured in 6-well plates for 6 h and then co-incubated for 1 h with 100 μmol/L dicoumarol, an inhibitor of JNK activation [22] , before treatment with 400 μmol/L genipin. After treatment for 24 h, the cells were washed with PBS, fixed in 10% formaldehyde solution for 5 min at room temperature and resuspended in 50 μL of PBS before deposition on cover slips. The adhered cells were incubated with Hoechst 33258 for 20 min at room temperature. Cover slips were rinsed with PBS and imaged by fl uorescence microscopy (Nikon Eclipse ET2000-E, Japan). Three replicate wells were analyzed for each treatment by the quantitative and qualitative examination of three random fields in each well. Cell viability was calculated from the number of viable cells excluding apoptotic nuclei vs the total number of nuclei in each well.
Statistical analysis
Data were presented as the mean±SD and were representative of three independent experiments. Statistical differences were evaluated using the Student's t-test.
Results
Effect of genipin on cell viability
The effect of genipin on cell viability was evaluated by the trypan blue dye exclusion method; cells were counted with a hemocytometer. A significant decrease in viable cells and total cell number was detected after treatment with genipin for 24 h. Cell viability decreased to 22.75% of the control after treatment with genipin 500 μmol/L (Figure 2 ). The IC 50 of genipin in K562 cells was approximately 250 μmol/L. Genipin showed dose-dependent cytotoxic and antiproliferative effects on K562 cells.
Morphological changes in genipin-treated K562 cells
To better clarify the changes in cell morphology induced by genipin, K562 cells were exposed to the indicated concentrations of genipin for 24 h and then observed under a microscope. As shown in Figure 3 , characteristic morphological changes were observed in K562 cells. Control K562 cells had normal features with round and homogeneous nuclei ( Figure  3A ). Signifi cant morphological changes were observed in the cells after treatment with genipin. Cells exhibited the characteristic features of apoptosis such as cell shrinkage, membrane blebbing, and the appearance of apoptotic bodies ( Figure  3B-3D, arrows) . Genipin was found to inhibit the growth of K562 cells and increase the number of apoptotic cells in a dosedependent manner. The exposure of K562 cells to 400 μmol/L genipin resulted in the most obvious apoptotic phenomena.
DNA fragmentation
An important feature of apoptosis is the fragmentation of 
Involvement of caspase 3 in genipin-induced apoptosis
We examined whether apoptosis is induced in genipin-treated K562 cells and when the cells become apoptotic. We measured the activity of caspase 3, the critical mediator of apoptosis, in cytosolic extracts using Ac-DEVD-MCA as its fluorogenic substrate. Genipin signifi cantly activated caspase 3 after 6 h of treatment; the trend increased slightly near 24 h ( Figure 5 ). (Table 1) . Moreover, it occurred in a dosedependent manner. Treatment with genipin significantly altered the cell cycle profile and increased the number of apoptotic cells, demonstrating that the decrease in cell viability is due to an induction in cell apoptosis and is related to cell cycle arrest. These fi ndings support the conclusions that the induction of cell death is due to apoptosis and that genipin arrests K562 cells at the G 2 /M phase.
Activation of JNK and phosphor-c-Jun expression in genipintreated K562 cells
To elucidate the signaling pathways involved in the genipininduced apoptosis of K562 cells, we evaluated the expression of phosphor-JNK and phosphor-c-Jun, a target of JNK, by using Western blotting. JNK has three isoforms (JNK 1 , JNK 2 , and JNK 3 ) with splicing variants that are either p46 or p54 in size [23] . Obvious p-JNK and p-c-Jun bands were detected. The results showed that the protein levels of p-JNK and p-c-Jun were increased in a dose-dependent manner; they were dramatically increased after treatment with 500 μmol/L genipin in comparison to the control ( Figure 7A, 7B) . The protein level npg of p-p38, another stress kinase and member of MAPK family, did not change signifi cantly in the K562 cells exposed to genipin ( Figure 7C ).
Fas-L and p63 expression in genipin-treated K562 cells
To further confirm that apoptosis was induced by genipin through the death-receptor pathway, Fas-L and p63, two signaling proteins in the apoptotic pathways, were detected by Western blot analysis. The expression of death-receptor Fas-L was induced by genipin in a concentration-dependent manner ( Figure 8 ). Because K562 cells lack functional p53 [24] , the expression of p63 in genipin-treated K562 cells was investigated. Genipin downregulated the expression of p63 ( Figure  8 ). p63 in general and one of its specific isoforms, ΔNp63α, are overexpressed in a variety of squamous cell cancers. However, their expression is downregulated in apoptotic cells [25] . These results demonstrated that the genipin-induced apoptosis is accompanied by the up-regulation of Fas-L and the downregulation of p63 in K562 cells.
Increase in Bax expression and cytochrome c release after genipin treatment
To clarify whether the mitochondria-dependent pathway is involved in genipin-induced apoptosis, the expression of Bax and the efflux of cytochrome c into the cytosol were examined in genipin-treated K562 cells using Western blotting. As shown in Figure 9 , accumulation of the Bax protein was observed and cytochrome c content increased signifi cantly in the cytosol of genipin-treated K562 cells. These results showed that genipin-induced apoptosis resulted in cytochrome c release from the mitochondria into the cytosol in K562 cells.
Activation of JNK in genipin-induced apoptosis
As shown in Figure 7 , the activation of JNK was involved in genipin-induced apoptosis in K562 cells. To clarify the role of JNK activation, we tested the effect of dicoumarol, a JNK inhibitor [22] , on genipin-induced apoptosis and JNK activation. Nuclear fragmentation in K562 cells treated for 24 h with 400 μmol/L genipin was determined by Hoechst 33258 staining ( Figures 10E and 10F ). Apoptotic bodies containing nuclear fragments were found only in genipin-treated cells; the nuclear envelope appeared lytic and the cytoplasm had shrunk (Figures 10E and 10F) . In contrast, cells cultured with dicoumarol only (Figures 10C and 10D) or with genipin and dicoumarol ( Figures 10G and 10H) showed normal cell nuclei morphology as in the control (Figures 10A and 10B) . These results showed that dicoumarol markedly suppressed the formation of apoptotic bodies and inhibited genipin-induced JNK activation. Additionally, the results of cell viability analyses in Figure 10I revealed that genipin-induced apoptosis was effectively inhibited by the addition of a JNK inhibitor. Taken together, these results indicated that the JNK signaling pathway mediated the genipin-induced apoptosis in K562 cells. 
Discussion
In recent years, genipin has been found to display potent anticancer effects. Genipin has been reported to induce apoptosis in FaO rat hepatoma cells, human hepatocarcinoma Hep3B cells and PC3 human prostate cancer cells [13, 14] . However, the exact mechanism of genipin-induced apoptosis has not yet to be determined. The present study demonstrates that genipin, a plant-derived iridoid, induces apoptosis in human K562 leukemia cells in a dose-dependent manner involving the activation of JNK/Fas-L signaling and G 2 /M arrest.
Apoptosis is characterized by specific morphological changes such as condensation of chromatin, nuclear fragmentation, blebbing of the plasma membrane, and the presence of apoptotic bodies [26] . We observed the typical characteristics of apoptosis in genipin-treated K562 cells using phase-contrast microscopy ( Figure 3 ) and fluorescence microscopy ( Figure  10 ). DNA fragmentation, a hallmark of apoptosis, was demonstrated by fragments ranging in size from 180 to 200 bp ( Figure 4 ). Inhibition of cell viability (Figure 2 ) and the formation of a sub-G 1 peak of apoptosis ( Figure 6 ) were observed in a dose-dependent manner. These results demonstrated that the death of K562 cells induced by genipin was due to apoptosis. Caspase 3, one of the crucial mediators of apoptosis, is an executioner caspase that can be activated by a mitochondrial pathway or a death receptor pathway [27] . Activation of caspase 3 was observed in genipin-treated cells and increased dramatically after 6 h of incubation ( Figure 5) .
Perturbation of the progression of the cell cycle is a signal that can trigger apoptotic cell death [28] . Several studies have reported that various cytotoxic drugs can induce G 2 /M phase arrest. As shown in Figure 6 , genipin induced the dose-dependent accumulation of cells in the G 2 /M phase of the cell cycle with subsequent accumulation in the sub-G 1 phase suggesting the sequential events of cell cycle arrest followed by apoptosis. Innocente et al [29] reported that p53 arrested the cells at the G 2 /M phase. However, we determined by Western blot that K562 cells were defi cient in functional p53 (data not shown), which was consistent with the results of Lubbert et al [24] . Mutation or dysfunction of p53 is found in more than half of all human cancers. However, p63, a transcription factor homologous to p53, was found to be gradually reduced in a dosedependent manner in our study (Figure 8 ). p63 has a critical physiological function. There is evidence that p63 in general and its specifi c ΔNp63α isoform are overexpressed in a variety of squamous cell cancers and in other types of cancers and could act as oncogenes [25, 30, 31] . Stravopodis et al [32] reported the dose-dependent attenuation of p63 expression in RT4 cells at the mRNA level in doxorubicin-induced apoptosis. This result [13] . It has also been reported that JNK plays an important role in IQDMA-mediated G 2 /M arrest and apoptosis of K562 cancer cells [33] . Although JNK and p38 MAPKs are collectively termed stress-activated protein kinases and are activated by a variety of stress-related stimuli and chemotherapy drugs [15, 16] , there was no obvious change in p-p38 ( Figure  7C ) in our studies. Kim et al [13] reported that the phosphorylation of JNK was clearly detectable in genipin-treated FaO cells, whereas MEK1/2 and p38 MAPKs were not activated after genipin treatment. Here, genipin dose-dependently upregulated the phosphorylation levels of JNK in K562 cells ( Figure  7A ). The effect of JNK was supported by dose-dependent phosphorylation of c-Jun, a substrate of JNK ( Figure 7B ). Furthermore, the involvement of JNK activation was confirmed by the use of dicoumarol (a JNK inhibitor) [22] (Figure 10 ). These results suggest that the genipin-induced apoptosis in K562 cells occurs through the JNK activation pathway.
The Fas/Fas-L pathway is an important cellular pathway regulating the induction of apoptosis in a variety of cell types. JNK has been found to contribute to death receptor apoptotic signaling via c-Jun/AP-1, which leads to the transcriptional activation of Fas-L [19] . Peng et al [34] suggested that JNK/Fas plays a pivotal role in (Ac) 5 GP-induced apoptosis. In the present study, the expression of Fas-L in genipin-treated K562 cells was found to increase dose-dependently (Figure 8 ), suggesting that genipin triggered Fas-L signaling following JNK activation and induced the death receptor apoptotic pathway in K562 cells. Mundt et al [35] suggested that the ΔNp63α isoform of p63 negatively regulated genes encoding Fas. Thus, p63 downregulation may regulate Fas/Fas-L activation. These results indicate that the activation of Fas-L might be attributed to both JNK activation and p63 downregulation in genipintreated K562 cells; Fas-L is then able to activate caspases to induce apoptosis.
Bax is a member of Bcl-2 family and also plays a crucial role in apoptosis as a proapoptotic protein. Accumulation of the Bax protein was observed ( Figure 9 ) and cytochrome c content was signifi cantly increased in the cytosol of genipintreated K562 cells suggesting that genipin-induced apoptosis also occurs through the mitochondrial apoptotic pathway. It has been reported that genipin induces apoptotic cell death in PC3 cells via JNK-dependent activation of the mitochondrial pathway [14] . Several experiments also revealed that activation of the JNK pathway can also cause cytochrome c release from the mitochondria to the cytosol and that apoptotic stimuli fail to release cytochrome c in JNK null cells [36] . Additionally, the ΔNp63α isoform repressed apoptosis-related genes of the mitochondrial apoptotic pathway [35] . In conclusion, a signaling pathway associated with genipininduced apoptosis in K562 cells was preliminarily examined in the present study. Treatment of K562 cells with genipin resulted in G 2 /M phase cell cycle arrest and cell apoptosis in a dose-dependent manner. Additionally, the activation of JNK was shown to play a crucial role in genipin-induced apoptosis in K562 cells. Downregulation of p63 may result in both Fas-L activation and cytochrome c release, which are related to the death receptor pathway and mitochondrial apoptotic pathway, respectively. These changes lead to caspase 3 activation and the ultimate induction of apoptosis in K562 cells. Further studies will be performed on the specifi c apoptotic signaling pathways in genipin-induced apoptosis in K562 cells. Taken together, our research provided important insights into the anticancer activity of genipin.
